A NovoPath alternative.
A fair, factual comparison of Labrynix and NovoPath for genetic, molecular, and PGx labs — based on category and architecture, not feature trash-talk. Here's where each fits.
NovoPath — Cloud pathology LIS.
NovoPath (NovoPath 360) is a cloud-based LIS built for anatomic, molecular, reference, and veterinary pathology — unifying case management, specimen tracking, reporting, and collaboration.
- High-throughput pathology efficiency
- Digital-pathology and AI readiness
- Cloud SaaS delivery with EMR integrations
Where Labrynix is different.
NovoPath is a cloud pathology LIS. Labrynix covers the same operations and then adds reporting, billing visibility, and a lab-trained AI layer across genetic, molecular, and PGx specialties — one platform instead of a LIS plus separate reporting and billing tools.
Cloud pathology LIS
All-in-one LIS/LIMS operations + reporting + billing visibility + a lab-trained AI layer — built inside a working CLIA-certified genetic lab.
What to weigh in any comparison.
Compliance & validation
CLIA/CAP fit, a complete audit trail, electronic sign-out, and validation support (IQ/OQ/PQ). Ask to see the audit trail live, not after signing.
Integration depth
Named HL7 v2 / FHIR / EHR connectors and bidirectional instrument integration — and whether new interfaces are configuration or a custom project.
Billing & denials
Molecular claims are denied often on first pass. Look at clean-claim support, Z-Code/CPT accuracy, prior-auth handling, and denial visibility.
Specimen lineage
For molecular/NGS work, parent–child tracking of aliquots, extractions, and libraries back to the original specimen — not a sample treated as monolithic.
Implementation & ownership
Go-live timeline, configuration vs custom code, who owns your data, and the data-return/exit terms if you ever leave.
AI you can defend
Explainable, grounded, audit-logged, human-in-the-loop assistance — never autonomous interpretation. Your qualified staff validate and sign out every result.
A fair-comparison note
NovoPath is a respected platform, and capabilities change over time. Details here are drawn from NovoPath's own public materials and reflect category and architecture, not a feature-by-feature scorecard — always confirm current capabilities directly with each vendor. Vendor-stated figures are attributed, not independently verified.
Questions,
answered.
See Labrynix next to your own workflow.
The fairest comparison is your real sample-to-report process. We'll run the demo on it.